AETHLON MEDICAL, INC. Restricted Cash, Noncurrent
AETHLON MEDICAL, INC. (AEMD) had Restricted Cash, Noncurrent of $98.93 thousand as of 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2026-06-10
- 2026-03-31: Restricted Cash, Noncurrent $98.93K.
- 2025-03-31: Restricted Cash, Noncurrent $97.81K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2026-03-31 | $98.93K 10-K · filed 2026-06-10 |
| 2025-03-31 | $97.81K 10-K · filed 2026-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |